What is Akebia Therapeutics Inc. (AKBA) Stock Return on Shareholders’ Capital?
With 3.81 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.78 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.48 and its lowest point at $0.59 during that stretch. It currently has a 1-year price target of $5.00. Beta for […]
A Look at Akebia Therapeutics Inc. (AKBA) Shares in the Recent Past Indicates Growth
With 3.73 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.6 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.48 and its lowest point at $0.51 during that stretch. It currently has a 1-year price target of $5.00. Beta for […]
A better buy-in window may exist right now for Akebia Therapeutics Inc. (AKBA)
With 14.01 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.16 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.48 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $5.00. Beta for […]
Does Akebia Therapeutics Inc. (AKBA) offer a good opportunity for investors?
With 10.11 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.94 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.33 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.33. Beta for […]
A better buy-in window may exist right now for Akebia Therapeutics Inc. (AKBA)
With 4.32 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.55 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.05 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.33. Beta for […]
You might want to take a look at Akebia Therapeutics Inc. (AKBA) now
With 3.35 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.13 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.4400 whereas the lowest price it dropped to was $1.3600. The 52-week range on AKBA shows […]
Check out these key findings about Akebia Therapeutics Inc. (AKBA)
With 3.5 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.92 million shares. The 52-week range on AKBA shows that it touched its highest point at $1.84 and its lowest point at $0.49 during that stretch. It currently has a 1-year price target of $4.33. Beta for […]
